During Berkeley Talks episode 195, UC Berkeley professors delved into the evolution of psychedelic substances, their effects on the human brain and mind, and the potential therapeutic role they may play. Psychology Professor Gül Dölen highlighted the importance of not only focusing on the experience during a psychedelic trip but also on the weeks that follow, when the critical period for learning and integration of insights is still open.
The panelists at the March 27, 2024 event included Imran Khan, the executive director of the Berkeley Center for the Science of Psychedelics (BCSP), Gül Dölen, a psychology professor specializing in psychedelics and neuroscience, Daniela Kaufer, a professor in the Department of Integrative Biology and an associate dean of biological sciences, Noah Whiteman, a professor of integrative biology and molecular and cell biology, and Michael Silver, a professor in the Herbert Wertheim School of Optometry and Vision Science.
They discussed the potential benefits and risks of engaging with psychedelics in a therapeutic context, emphasizing the need for careful attention to the environment and support system for individuals during and after their psychedelic experiences. By understanding the mechanisms involved in the therapeutic effects of psychedelics and taking a holistic approach to treatment, researchers and clinicians can maximize the potential benefits of these substances for mental health.